ARCHIVES

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

This article is from The Cancer Letter archive.

Vol. 31 No. 02 | January 14, 2005

Download PDF Visit The Full Archive

Related Articles

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

November 14, 2008

Diet & Nutrition Wins Ok To Use Program Grants

February 20, 1976

NCAB Asks Government To Take Steps Aimed at Reducing Health Hazards From Cigarettes

December 21, 1973

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992